REFERENCES

Abbott J. (1995) Clinical and microscopic diagnosis of vaginal yeast infection: a prospective
analysis. Annals of emergency medicine. 25(5):587-91.

Achkar, J. M., & Fries, B. C. (2010). Candida infections of the genitourinary tract. Clinical
Microbiology Reviews, 23(2), 253–273. https://doi.org/10.1128/CMR.00076-09

Africa CWJ, dos Santos Abrantes PM. (2016) Candida antifungal drug resistance in sub-Saharan
African populations: a systematic review. F1000Research. 5.

Aguin, T. J., & Sobel, J. D. (2015). Vulvovaginal Candidiasis in Pregnancy. Current Infectious
Disease Reports, 17(6), 15–20. https://doi.org/10.1007/s11908-015-0462-0

Ahmad, A., & Khan, A. U. (2009). Prevalence of Candida species and potential risk factors for
vulvovaginal candidiasis in Aligarh, India. European Journal of Obstetrics and Gynecology and
Reproductive Biology, 144(1), 68–71. https://doi.org/10.1016/j.ejogrb.2008.12.020

Akah, P. A., Nnamani, C. E., & Nnamani, P. O. (2010). Prevalence and treatment outcome of
vulvovaginal candidiasis in pregnancy in a rural community in Enugu State, Nigeria. Journal of
Medicine and Medical Sciences, 1(November), 447–452.

Al-Aali, K. Y. (2013). Prevalence of Vaginal Candidiasis among Pregnant Women Attending Al-
Hada Military Hospital, Western Region, Taif, Saudi Arabia. International Journal of Science
and Research, 4(8), 1736–1743. www.ijsr.net

Al-Rukeimi, A. A., Al-Hatami, S. M. M., AL-Danany, D. A., Al-Shamahy, H. A., & Al

Rukeimi, R. A. A. (2020). Prevalence and Risk Factors Associated With Vulvovaginal
Candidiasis During Pregnancy in Sana’a, Yemen. Universal Journal of Pharmaceutical
Research, 5(3), 1–5. https://doi.org/10.22270/ujpr.v5i3.407

Al-Rusan RM, Darwazeh AM, Lataifeh IM. (2017) The relationship of Candida colonization of
the oral and vaginal mucosae of mothers and oral mucosae of their newborns at birth. Oral
surgery, oral medicine, oral pathology and oral radiology. 123(4):459-63.

Altayyar, I. A., Alsanosi, A. S., & Osman, N. A. (2016). Prevalence of vaginal candidiasis
among pregnant women attending different gynecological clinic at South Libya. Pelagia
Research Library European Journal of Experimental Biology, 6(3), 25–29.
www.pelagiaresearchlibrary.com

Anh DN, Hung DN, Tien TV, Dinh VN, Son VT, Luong NV, et al. (2021) Prevalence, species
distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among
symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC
infectious diseases. 21(1):523.

Apalata T, Longo-Mbenza B, Sturm A, Carr W, Moodley P. (2014) Factors associated with

symptomatic vulvovaginal candidiasis: a study among women attending a primary healthcare
clinic in Kwazulu-Natal, South Africa. Annals of medical and health sciences research. 4(3):410-
6.

Babić, M., & Hukić, M. (2010). Candida albicans andon-albicans species as etiological agent of
vaginitis in pregnant and non-pregnant women. Bosnian Journal of Basic Medical Sciences,
10(1), 89–97. https://doi.org/10.17305/bjbms.2010.2744

Barasch, A. and Griffin, A. V., (2008) Miconazole revisited: new evidence of antifungal efficacy
from laboratory and clinical trials. Future Microbiology, 3 (3), 265–269.

Bassetti, M., Mikulska, M., and Viscoli, C., (2010) Bench-to-bedside review: therapeutic
management of invasive candidiasis in the intensive care unit. Critical Care, 14 (6), 244.

Bliss, J. M., Basavegowda, K. P., Watson, W. J., Sheikh, A. U., & Ryan, R. M. (2008). Vertical
and horizontal transmission of candida albicans in very low birth weight infants using DNA
fingerprinting techniques. Pediatric Infectious Disease Journal, 27(3), 231–235.
https://doi.org/10.1097/INF.0b013e31815bb69d

Bohbot, J. M., Sednaoui, P., Verriere, F. and Achhammer, I. (2011). "Diversité étiologique des
vaginites." Gynécologie Obstétrique & Fertilité:
http://dx.doi.org/10.1016/j.gyobfe.2011.1008.1001.

Brandão, L. D. S., Boniek, D., Resende Stoianoff, M. A., da Mata, F. M. R., de Azevedo, P. R.
M., Fernandes, J. V., & Andrade, V. S. (2018). Prevalence and antifungal susceptibility of
Candida species among pregnant women attending a school maternity at Natal, Brazil. Letters in
Applied Microbiology, 67(3), 285–291. https://doi.org/10.1111/lam.13034
Brunton, L.L., (2011) Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed.
The McGraw-Hill Companies, Inc.

Carr, P., Felsenstein, D. and Friedman, R. (1998). "Evaluation and management of vaginitis."
Journal of General Internal Medicine 13(5): 335-346.

Cavalheiro M, Teixeira MC. (2018) Candida biofilms: threats, challenges, and promising
strategies. Frontiers in medicine. 5:28.

Choo, Z.W., et al., (2010) A comparative histopathological study of systemic candidiasis in

association with experimentally induced breast cancer. Oncology Letters, 1 (1), 215–222.

Cotch, M. F., Hillier, S. L., Gibbs, R. S., Eschenbach, D. A., Yaffe, S. J., Catz, C. S., Rhoads, G.
G., Nugent, R. P., McNellis, D., Klebanoff, M. A., Berendes, H. W., Edelman, R., Blackwelder,
W. C., Kaslow, R. A., Reed, G. F., Regan, J. A., Greenberg, E. M., Willams, S., Martin, D. A.,
… Poole, W. K. (1998). Epidemiology and outcomes associated with moderate to heavy Candida
colonization during pregnancy. American Journal of Obstetrics and Gynecology, 178(2), 374–
380. https://doi.org/10.1016/S0002-9378(98)80028-8

Conti HR, Huppler AR, Whibley N, Gaffen SL. (2014) Animal models for candidiasis. Current
protocols in immunology. 105(1):19.6. 1-.6. 7.

das Neves, J., Amaral, M. H. and Bahia, M. F. (2008). "Performance of an in vitro mucoadhesion
testing method for vaginal semisolids: Influence of different testing conditions and instrumental
parameters." European Journal of Pharmaceutics and Biopharmaceutics 69(2): 622-632.

da Silva Dantas A, Lee KK, Raziunaite I, Schaefer K, Wagener J, Yadav B, et al. (2016) Cell
biology of Candida albicans–host interactions. Current opinion in microbiology. 34:111-8.52

Dias, L. B., Melhem, M. de S. C., Szeszs, M. W., Filho, J. M., & Hahn, R. C. (2011).
Vulvovaginal candidiasis in Mato Grosso, Brazil: Pregnancy status, causative species and drugs
tests. Brazilian Journal of Microbiology, 42(4), 1300–1307. https://doi.org/10.1590/S1517-
83822011000400009

Donders, G.G., et al., (2002) Definition of a type of abnormal vaginal flora that is distinct from
bacterial vaginosis: aerobic vaginitis. British Journal of Gynecology, 109 (1), 34–43.
Edrees, W. H., Al-Asbahi, A. A., Al-Shehari, W. A., & Qasem, E. A. (2020). Vulvovaginal
Candidiasis Prevalence Among Pregnant Women in Different Hospitals in Ibb, Yemen.
Universal Journal of Pharmaceutical Research, 5(4), 1–5. https://doi.org/10.22270/ujpr.v5i4.431

El-Houssaini HH, Elnabawy OM, Nasser HA, Elkhatib WF. (2019) Correlation between
antifungal resistance and virulence factors in Candida albicans recovered from vaginal
specimens. Microbial pathogenesis. 128:13-9.

Erdogan, A. and Rao, S.S., (2015) Small intestinal fungal overgrowth. Current Gastroenterology
Reports, 17 (4), 16.

Eschenbach, D. A. (2004). "Chronic Vulvovaginal Candidiasis." New England Journal of

Medicine 351(9): 851-852.

Ferris, D.G., et al., (2002) Over-the-counter antifungal drug misuse associated with patient-
diagnosed vulvovaginal candidiasis. Obstetrics and Gynecology, 99 (3), 419–425.

Filippidi A, Galanakis E, Maraki S, Galani I, Drogari‐Apiranthitou M, Kalmanti M, et al. (2014)

The effect of maternal flora on Candida colonisation in the neonate. Mycoses. 57(1):43-8.

Foessleitner, P., Petricevic, L., Boerger, I., Steiner, I., Kiss, H., Rieger, M. B. A. A., & Farr, V.
T. A. (2021). HIV infection as a risk factor for vaginal dysbiosis , bacterial vaginosis , and
candidosis in pregnancy : A matched case-control study. December 2020, 1–8.
https://doi.org/10.1111/birt.12526

Francois, I.E.J.A., et al., (2006) Azoles: mode of antifungal action and resistance development.
Effect of miconazole on endogenous reactive oxygen species production in Candida albicans.
Anti-Infective Agents in Medicinal Chemistry, 5, 3–13.

Ghaddar, N., Anastasiadis, E., Halimeh, R., Ghaddar, A., Dhar, R., Alfouzan, W., Yusef, H., &
El Chaar, M. (2020). Prevalence and antifungal susceptibility of Candida albicans causing
vaginal discharge among pregnant women in Lebanon. BMC Infectious Diseases, 20(1), 1–9.
https://doi.org/10.1186/s12879-019-4736-2

Ghaddar, N., El Roz, A., Ghssein, G., & Ibrahim, J. N. (2019). Emergence of Vulvovaginal
Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species
Distribution. Infectious Diseases in Obstetrics and Gynecology, (2019).
https://doi.org/10.1155/2019/5016810

Goehring, R.V., (2008) Mims’ medical microbiology. 4th ed. Mosby Elsevier.

Gow, N. A. R., & Yadav, B. (2017). Microbe profile: Candida albicans: A shape-changing,
opportunistic pathogenic fungus of humans. Microbiology (United Kingdom), 163(8), 1145–
1147. https://doi.org/10.1099/mic.0.000499

Grigoriou, O., Baka, S., Makrakis, E., Hassiakos, D., Kapparos, G., & Kouskouni, E. (2006).
Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors.
European Journal of Obstetrics and Gynecology and Reproductive Biology, 126(1), 121–125.
https://doi.org/10.1016/j.ejogrb.2005.09.015

Gulati M, Nobile CJ. (2016) Candida albicans biofilms: development, regulation, and molecular
mechanisms. Microbes and infection. 18(5):310-21.

Guzel, A. B., Ilkit, M., Burgut, R., Urunsak, I. F., & Ozgunen, F. T. (2011). An Evaluation of
Risk Factors in Pregnant Women with Candida Vaginitis and the Diagnostic Value of
Simultaneous Vaginal and Rectal Sampling. Mycopathologia, 172(1), 25–36.
https://doi.org/10.1007/s11046-011-9392-z

Hidalgo, J.A. and Vazquez, J.A., (2020) Candidiasis: clinical presentation. Medscape. Available
from: https://emedicine.medscape.com/article/213853-clinical.

Hillier, S.L. and Lau, R.J., (1997) Vaginal microflora in postmenopausal women who have not
received estrogen replacement therapy. Clinical Infectious Diseases, 25 (Suppl. 2), S123–S126.

Hynniewta BC, Chyne WW, Phanjom P, Donn R. (2019) Prevalence of Vaginal Candidiasis
among pregnant women attending Ganesh Das Government Maternity and Child Health hospital,
Shillong, Meghalaya, India.

Idowu MO, Makinde GI, Oluranti OO, Adebayo MA, Adekunle OA. (2022) Prevalence of
vulvo-vaginal candidiasis among women attending clinics in selected Hospitals in Oyo State,
Southwest, Nigeria. Journal of Public Health and Epidemiology. 14(1):45-52.
Ivanov, M., Ciric, A., and Stojkovic, D., (2022) Emerging antifungal targets and strategies.
International Journal of Molecular Sciences, 23 (5), 2756.

Jamieson, D. J. (2014). Pregnancy and Infection. 2211–2218.

https://doi.org/10.1056/NEJMra1213566

Jartarkar, S.R., et al., (2021) Pathogenesis, immunology and management of dermatophytosis.

Journal of Fungi, 8 (1), 39.

Jurden, L., et al., (2012) Clinical inquiries. Can probiotics safely prevent recurrent vaginitis?
Journal of Family Practice, 61 (6), 357, 368.

Kamath, P., Pais, M., & Nayak, M. G. (2013). Original Research Article Risk of vaginal
candidiasis among pregnant women. Int.J.Curr.Microbiol.App.Sci, 2(9), 141–146.
https://pdfs.semanticscholar.org/f9ac/6c5e90d3178ff5f6f39a9cc56ab26703926d.pdf

Kanagal, D. V. (2014). Prevalence of Vaginal Candidiasis in Pregnancy among Coastal South

Indian Women. Journal of Women’s Health, Issues & Care, 03(06), 1–3.
https://doi.org/10.4172/2325-9795.1000168

Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB. (2006) Patterns of
fungal colonization in preterm infants weighing less than 1000 grams at birth. The Pediatric
infectious disease journal. 25(8):733-7.

Kast, C. E., Valenta, C., Leopold, M. and Bernkop-Schnürch, A. (2002). "Design and in vitro
evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole." Journal of
Controlled Release 81(3): 347-354.

Kim, J. and Sudbery, P. (2011). "Candida albicans, a major human fungal pathogen." The
Journal of Microbiology 49(2): 171-177.

Kinghorn, G. R. (1991). Vulvovaginal candidosis. Journal of Antimicrobial Chemotherapy,

28(suppl A), 59–66. https://doi.org/10.1093/jac/28.suppl_A.59

Konadu, D. G., Owusu-Ofori, A., Yidana, Z., Boadu, F., Iddrisu, L. F., Adu-Gyasi, D., Dosoo,
D., Awuley, R. L., Owusu-Agyei, S., & Asante, K. P. (2019). Prevalence of vulvovaginal
candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic
in the middle belt of Ghana. BMC Pregnancy and Childbirth, 19(1), 1–10.
https://doi.org/10.1186/s12884-019-2488-z

Knuth, K., Amiji, M. and Robinson, J. R. (1993). "Hydrogel delivery systems for vaginal and
oral applications: Formulation and biological considerations." Advanced Drug Delivery Reviews
11(1-2): 137-167.

Kobayashi, D., et al., (2002) Endogenous reactive oxygen species is an important mediator of
miconazole antifungal effect. Antimicrobial Agents and Chemotherapy, 46 (10), 3113–3117.

Kufa T, Gumede L, Maseko D, Radebe F, Kularatne R. (2018) The demographic and clinical
profiles of women presenting with vaginal discharge syndrome at primary care facilities in South
Africa: associations with age and implications for management. South African Medical Journal.
108(10):876-80.

Mallipeddi, R. and Rohan, L. C. (2010). "Nanoparticle-based vaginal drug delivery systems for
HIV prevention." Expert Opinion on Drug Delivery 7(1): 37-48.

Marrazzo, J. M. (2011). "Interpreting the epidemiology and natural history of bacterial vaginosis:
Are we still confused?" Anaerobe 17(4): 186-190.

Mårdh, P.A., Novikova, N., and Stukalova, E., (2003) Colonisation of extragenital sites by
Candida in women with recurrent vulvovaginal candidosis. British Journal of Gynecology, 110
(10), 934–937.

Mashburn, J. (2006). "Etiology, Diagnosis, and Management of Vaginitis." The Journal of

Midwifery & Women’s Health 51(6): 423-430.

Masri, S. N., Noor, S. M., Mat Nor, L. A., Osman, M., & Rahman, M. M. (2015). Candida
isolates from pregnant women and their antifungal susceptibility in a Malaysian tertiary-care
hospital. Pakistan Journal of Medical Sciences, 31(3), 658–661.
https://doi.org/10.12669/pjms.313.7229

Mendling, W., & Brasch, J. (2012). Guideline vulvovaginal candidosis (2010) of the german
society for gynecology and obstetrics, the working group for infections and infectimmunology in
gynecology and obstetrics, the german society of dermatology, the board of german
dermatologists and the. Mycoses, 55(SUPPL. 3), 1–13. https://doi.org/10.1111/j.1439-
0507.2012.02185.x

Merabet, J., Thompson, D. and Saul Levinson, R. (2005). "Advancing vaginal drug delivery."
Expert Opinion on Drug Delivery 2(4): 769-777.

Mitchell KF, Zarnowski R, Sanchez H, Edward JA, Reinicke EL, Nett JE, et al. (2015)
Community participation in biofilm matrix assembly and function. Proceedings of the National
Academy of Sciences. 112(13):4092-7.

Mohammadi-Ghalehbin, B., Javanpour Heravi, H., Arzanlou, M., & Sarvi, M. (2017).
Prevalence and Antibiotic Resistance Pattern of Candida spp; Isolated From Pregnant Women
Referred to Health Centers in Ardabil, Iran. Journal of Ardabil University of Medical Sciences,
16(4), 409-421.

Mølgaard-Nielsen, D., Svanström, H., Melbye, M., Hviid, A., & Pasternak, B. (2016).
Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion
and stillbirth. JAMA - Journal of the American Medical Association, 315(1), 58–67.
https://doi.org/10.1001/jama.2015.17844

Morace G, Perdoni F, Borghi E. (2014) Antifungal drug resistance in Candida species. Journal of
Global Antimicrobial Resistance. 2(4):254-9.

Mousavi SA, Khalesi E, Bonjar GS, Aghighi S, Sharifi F, Aram F. (2007) Rapid molecular
diagnosis for Candida species using PCR-RFLP. Biotechnology. 6(4):583-7.

Mtibaa, L., Fakhfakh, N., Kallel, A., Belhadj, S., Belhaj Salah, N., Bada, N., & Kallel, K. (2017).
Les candidoses vulvovaginales : étiologies, symptômes et facteurs de risque. Journal de
Mycologie Medicale, 27(2), 153–158. https://doi.org/10.1016/j.mycmed.2017.01.003

Mucci, M. J., Cuestas, M. L., Landanburu, M. F., & Mujica, M. T. (2017). Prevalence of
Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from
vulvovaginal candidiasis in Argentina. Revista Iberoamericana de Micologia, 34(2), 72–76.
https://doi.org/10.1016/j.riam.2016.09.001

Mulley, A.G. and Goroll, A.H., (2006) Primary care medicine: office evaluation and
management of the adult patient. Wolters Kluwer Health.
Nama Z, AL-Janabi A, Abdul Wahid H, AL-Janabi A. (2021) Vulvovaginal candidiasis: The
infection should explain itself. Int J. 4:261.

Nelson, M., Wanjiru, W., & Margaret, M. W. (2013). Prevalence of Vaginal Candidiasis and
Determination of the Occurrence of Candida Species in Pregnant Women Attending the
Antenatal Clinic of Thika District Hospital, Kenya. Open Journal of Medical Microbiology,
03(04), 264–272. https://doi.org/10.4236/ojmm.2013.34040

Nnadi, D. C., & Singh, S. (2017). The prevalence of genital Candida species among pregnant
women attending antenatal clinic in a tertiary health center in North-west Nigeria. Sahel Medical
Journal, 20(1), 33–37. https://doi.org/10.4103/1118-8561.204333

Nyirjesy, P. and Sobel, J.D., (2013) Genital mycotic infections in patients with diabetes.
Postgraduate Medicine, 125 (3), 33–46.

Nwokolo, N.C. and Boag, F.C., (2000) Chronic vaginal candidiasis. Management in the
postmenopausal patient. Drugs & Aging, 16 (5), 335–339.

Odds FC. (1994) Pathogenesis of Candida infections. Journal of the American Academy of
Dermatology. 31(3):S2-S5.

Odds FC, Brown AJ, Gow NA. (2003) Antifungal agents: mechanisms of action. Trends in
microbiology. 11(6):272-9.

Okonkwo, N., & Umeanaeto, P. (2011). Prevalence of Vaginal Candidiasis among Pregnant
Women in Nnewi Town of Anambra State, Nigeria. African Research Review, 4(4), 539–548.
https://doi.org/10.4314/afrrev.v4i4.69250

Olowe, O., Makanjuola, O., Olowe, R., & Adekanle, D. (2014). Prevalence of vulvovaginal
candidiasis, trichomoniasis and bacterial vaginosis among pregnant women receiving antenatal
care in Southwestern Nigeria. European Journal of Microbiology and Immunology, 4(4), 193–
197. https://doi.org/10.1556/eujmi-d-14-00027

Owen, M. K. and Clenney, T. L. (2004). "Management of vaginitis." American Family Physician

70(11): 2125-2132.
Pandey N, Gupta MK, Tilak R. (2018) Extracellular hydrolytic enzyme activities of the different
Candida spp. isolated from the blood of the Intensive Care Unit-admitted patients. Journal of
laboratory physicians. 10(04):392-6.

Paulitsch, A., Weger, W., Ginter-Hanselmayer, G., Marth, E., & Buzina, W. (2006). A 5-year
(2000-2004) epidemiological survey of Candida and non-Candida yeast species causing
vulvovaginal candidiasis in Graz, Austria. Mycoses, 49(6), 471–475.
https://doi.org/10.1111/j.1439-0507.2006.01284.x

Pavelić, Ţ., Škalko-Basnet, N. and Schubert, R. (2001). "Liposomal gels for vaginal drug
delivery." International Journal of Pharmaceutics 219(1-2): 139-149.

Pazos, M., Sperling, R. S., Moran, T. M., & Kraus, T. A. (2012). The influence of pregnancy on
systemic immunity. 254–261. https://doi.org/10.1007/s12026-012-8303-9

Poojary, S.A., 2017. Topical antifungals: a review and their role in current management of
dermatophytoses. Clinical Dermatology Review, 1, S24–S29.

Potokoué Mpia N, Sékangué Obili G, Ossibi Ibara B, Djendja Ingoba I, Buambo G, Gackosso G.
(2021) Vaginal candidiasis in women of childbearing age at the university hospital of
Brazzaville: prevalence and associated factors. Microbiol Infect Dis. 5(3):1-5.

Pramanick R, Mayadeo N, Warke H, Begum S, Aich P, Aranha C. (2019) Vaginal microbiota of

asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal
microbiota? Microbial pathogenesis. 134:103599.

Rachapromma, P. and Chayachinta, C., 2022. Care for women with acute vaginal candidiasis.
Siriraj Medical Bulletin, 15 (2), 107–113.

REED, B. D. (1992). Risk Factors for Candida Vulvovaginitis. Obstetrical & Gynecological
Survey, 47(8), 551–560. https://doi.org/10.1097/00006254-199208000-00015

Reed BD, Zazove P, Pierson CL, Gorenflo DW, Horrocks J. (2003) Candida transmission and
sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. Journal of Women's
Health. 12(10):979-89.
Reza F, Mehr AR, Fatemeh R, Masoud H. (2012) Prevalence of vaginal candidiasis infection in
diabetic women. African Journal of Microbiology Research. 6(11):2773-8.

Rodríguez-Cerdeira C, Martínez-Herrera E, Carnero-Gregorio M, López-Barcenas A, Fabbrocini

G, Fida M, et al. (2020) Pathogenesis and clinical relevance of Candida biofilms in vulvovaginal
candidiasis. Frontiers in Microbiology. 11:544480.

Roudbary M, Roudbarmohammadi S, Bakhshi B, Farhadi Z, Nikoomanesh F. (2013)

Identification of Candida species isolated from Iranian women with vaginal candidiasis by PCR-
RFLP method. Eur J Exp Biol. 3(6):365-9.

Sadaqat A, Batool H, Ambreen A. (2020) Diabetes in Pregnancy: High Risk for Vulvovaginal
Candidiasis. Annals of King Edward Medical University. 26(1):72-6.

Sangaré, I., Sirima, C., Bamba, S., Zida, A., Cissé, M., Bazié, W. W., Sanou, S., Dao, B., Menan,
H., & Guiguemdé, R. T. (2018). Prevalence of vulvovaginal candidiasis in pregnancy at three
health centers in Burkina Faso. Journal de Mycologie Medicale, 28(1), 186–192.
https://doi.org/10.1016/j.mycmed.2017.08.006

Schell WA, Kauffman C, Thorner A. (2017) Biology of Candida infections. Outubro.

Sharp A, Odds F, Evans E. (1992) Candida strains from neonates in a special care baby unit.
Archives of disease in childhood. 67(1 Spec No):48-52.

Sherrard J. (2019) Evaluation of the BD MAX™ Vaginal Panel for the detection of vaginal
infections in a sexual health service in the UK. International journal of STD & AIDS. 30(4):411-
4.

Shrestha, S., Tuladhar, N. R., Basnyat, S., Acharya, G. P., Shrestha, P., & Kumar, P. (2011).
Prevalence of vaginitis among pregnant women attending Paropakar Maternity and Women’s
Hospital, Thapathali, Kathmandu, Nepal. Nepal Medical College Journal: NMCJ, 13(4), 293–
296.

Shu’aibu I, Tennu P, Fatima U, Ibrahim L, Muhammad M. (2013) Incidence of vulvovaginal

candidiasis associated with Candida albicans among pregnant women attending Gombe State
Specialist Hospital, Gombe, Nigeria. Bayero Journal of Pure and Applied Sciences. 6(2):84-8.
Siddiqui R. (2019) Clinical patterns and risk factors of vulvo-vaginal candidiasis among women
of reproductive age attending a tertiary hospital in central India. Stamford Journal of
Microbiology. 9(1):27-31.

Siddique U, Latif H, Hameed A, Rathore R, Farooq Butt N, Iqbal A. (2018) Prevalence of

Vulvo-Vaginal Candidiasis in Diabetic and Non-diabetic Pregnant Females. PJMHS. 12(2):742-
5.

Sobel, J. D., Faro, S., Force, R. W., Foxman, B., Ledger, W. J., Nyirjesy, P. R., Reed, B. D., &
Summers, P. R. (1998). Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic
considerations. American Journal of Obstetrics and Gynecology, 178(2), 203–211.
https://doi.org/10.1016/S0002-9378(98)80001-X

Sobel, J. D. (1997). "Vaginitis." New England Journal of Medicine 337(26): 1896-1903.

Sobel, Jack D. (2007). Vulvovaginal candidosis. Lancet, 369(9577), 1961–1971.

https://doi.org/10.1016/S0140-6736(07)60917-9

Srikumar, C. and Nagaraja, H., 2011. A comprehensive review of the occurrence and
management of systemic candidiasis as an opportunistic infection. Microbiology Journal, 1, 1–7.

Straub, R. H. (2007). The Complex Role of Estrogens in Inflammation. 28(5), 521–574.

https://doi.org/10.1210/er.2007-0001

Sule-Odu AO, Akadri AA, Oluwole AA, Osinupebi OA, Andu BA, Lawal AI. (2020) Vaginal
Candida infection in pregnancy and its implications for fetal well-being. African Journal of
Reproductive Health. 24(3):33-40.

Thevissen, K., et al., (2007) Miconazole induces changes in actin cytoskeleton prior to reactive
oxygen species induction in yeast. Journal of Biological Chemistry, 282 (30), 21592–21597.

Thompson A, Timm K, Borders N, Montoya L, Culbreath K. (2020) Diagnostic performance of

two molecular assays for the detection of vaginitis in symptomatic women. European Journal of
Clinical Microbiology & Infectious Diseases. 39:39-44.

Toua, V., Djaouda, M., Gaké, B., Menye, D. E., Akoachere, E., Tambe, E., Akindoh, V. V., &
Njiné, T. (2013). Prevalence of Vulvovaginal Candidiasis amongst pregnant women in Maroua (
Cameroon ) and the sensitivity of Candida albicans to extracts of six locally used antifungal
plants. 4(March), 89–97.

Tsega, A., & Mekonnen, F. (2019). Prevalence, risk factors and antifungal susceptibility pattern
of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest
Ethiopia. BMC Pregnancy and Childbirth, 19(1), 1–8. https://doi.org/10.1186/s12884-019-2494-
1

Tsui C, Kong EF, Jabra-Rizk MA. (2016) Pathogenesis of Candida albicans biofilm. Pathogens
and disease. 74(4).

Valenta, C. (2005). "The use of mucoadhesive polymers in vaginal delivery." Advanced Drug
Delivery Reviews 57(11): 1692-1712.

Vanden Bossche, H., et al., 1990. Saperconazole: a selective inhibitor of the cytochrome P-450-
dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton
mentagrophytes. Mycoses, 33 (7–8), 335–352.

Van Schalkwyk, J., Yudin, M. H., Allen, V., Bouchard, C., Boucher, M., Boucoiran, I., Caddy,
S., Castillo, E., Kennedy, V. L., Money, D. M., Murphy, K., Ogilvie, G., & Paquet, C. (2015).
Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis,
and Bacterial Vaginosis. Journal of Obstetrics and Gynaecology Canada, 37(3), 266–274.
https://doi.org/10.1016/S1701-2163(15)30316-9

Vermitsky, J.P., et al., 2008. Survey of vaginal-flora Candida species isolates from women of
different age groups by use of species-specific PCR detection. Journal of Clinical Microbiology,
46 (4), 1501–1503.

Waikhom, S. D., Afeke, I., Kwawu, G. S., Mbroh, H. K., Osei, G. Y., Louis, B., Deku, J. G.,
Kasu, E. S., Mensah, P., Agede, C. Y., Dodoo, C., Asiamah, E. A., Tampuori, J., Korbuvi, J., &
Opintan, J. A. (2020). Prevalence of vulvovaginal candidiasis among pregnant women in the Ho
municipality, Ghana: Species identification and antifungal susceptibility of Candida isolates.
BMC Pregnancy and Childbirth, 20(1), 1–14. https://doi.org/10.1186/s12884-020-02963-3
Warren, T.R.N., 2010. Is it a yeast infection? WebMD. Available from:
https://www.webmd.com/women/features/is-it-yeast-infection.

Wegmann, T. G., Lin, H., Guilbert, L., & Mosmann, T. R. (1993). Bidirectional cytokine
interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? In
Immunology Today (Vol. 14, Issue 7, pp. 353–356). Elsevier Current Trends.
https://doi.org/10.1016/0167-5699(93)90235-D

Workowski, K.A. and Bachmann, L.H., 2022. Centers for disease control and prevention’s
sexually transmitted diseases infection guidelines. Clinical Infectious Diseases, 74 (74 Suppl. 2),
S89–S94. Workowski, K.A., et al., 2021. Sexually transmitted infections treatment guidelines,
2021. Morbidity and Mortality Weekly Report. Recommendations and Reports, 70 (4), 1–187.

Yadav, K., & Prakash, S. (2016). Prevalence of vulvovaginal candidiasis in pregnancy. Global
Journal of Medicine and Medical Sciences, 4(1), 108–116.
https://www.researchgate.net/publication/309572378 Alexander, N. J., Baker, E., Kaptein, M.,
Karck, U., Miller, L. and Zampaglione, E. (2004). "Why consider vaginal drug administration?"
Fertility and Sterility 82(1): 1-12.

Zhang, X., Yin, M., and Zhang, L.J., 2019. Keratin 6, 16 and 17-critical barrier alarmin
molecules in skin wounds and psoriasis. Cells, 8 (8), 807.